台股 » 個股 » 國邑* » 籌碼相關 » 券商分點績效 » 券商分點個股進出

國邑*

(6875)
  • 股價
    57.6
  • 漲跌
    ▼1.6
  • 漲幅
    -2.70%
  • 成交量
    348
  • 產業
    上櫃 生技醫療類股
  • 8人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
國邑* (6875)籌碼相關-富邦-陽明 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-陽明 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/11/2000.00759.5659.20-7270-2.59%
2024/11/1400.00163.2063.00-1282-0.35%
2024/11/1300.00163.5063.20-1282-0.35%
2024/11/082463.84264.2064.60222827.80%
2024/11/07462.00162.1062.9032801.07%
2024/11/061061.9100.0061.60102813.55%
2024/11/051761.7300.0061.40172855.96%
2024/11/042861.6300.0061.90282939.55%
2024/10/24264.1500.0063.9023140.64%
2024/10/1400.000.564.6264.60-0.5328-0.15%
2024/10/073.573.26771.8768.00-3.5324-1.08%
2024/10/0400.00171.1071.10-1296-0.34%
2024/09/3000.00466.2565.00-4293-1.36%
2024/09/26162.1000.0061.6012910.34%
2024/09/23163.0000.0062.8012970.34%
2024/09/20165.8000.0064.6012950.34%
2024/09/1900.00166.1066.00-1294-0.34%
2024/09/18165.30165.6065.1002940.00%
2024/09/13164.0000.0063.8012930.34%
2024/09/12164.2000.0064.2012940.34%
2024/09/11264.4500.0064.5022960.67%
2024/09/10163.9000.0063.4012970.34%
2024/09/09163.80265.5066.50-1294-0.34%
2024/09/0600.00265.8064.90-2292-0.68%
2024/09/05163.2000.0060.9012880.35%
2024/09/0400.00162.0061.30-1289-0.35%
2024/09/02266.30265.8566.000289-0.01%
2024/08/3000.008.161.8562.00-8.1280-2.89%
2024/08/2900.00259.5560.80-2279-0.71%
2024/08/2800.00259.2559.40-2279-0.72%
2024/08/27059.5000.0060.0002780.01%
2024/08/260.159.7800.0060.500.12770.04%
2024/08/23662.451.262.8261.504.82741.73%
2024/08/2200.00166.9066.90-1251-0.40%
2024/08/2100.00160.9060.90-1251-0.40%
2024/08/19155.5000.0056.4012510.40%
2024/08/16257.9000.0057.0022510.80%
2024/08/02361.0000.0059.5032711.11%
2024/08/01257.3500.0058.3022690.74%
2024/07/31357.53356.8056.6002690.00%
2024/07/29557.90458.0357.1012670.37%
2024/07/26558.0000.0059.5052791.79%
2024/07/23261.2000.0060.0022840.70%
2024/07/225.261.5500.0060.805.22881.82%
2024/07/1800.00166.3066.10-1291-0.34%
2024/07/16265.7500.0066.3022890.69%
2024/07/15264.75465.6365.10-2301-0.66%
2024/07/12364.7300.0064.8033060.98%
2024/07/11165.00165.9065.2003090.00%
2024/07/10165.3000.0065.2013170.31%
2024/07/0800.00567.1667.20-5333-1.50%
2024/07/05469.75268.0068.0023360.59%
2024/07/0400.00168.5068.40-1337-0.30%
2024/07/0300.00469.0068.80-4341-1.17%
2024/07/02169.801469.4769.30-13344-3.78%
2024/07/01170.2000.0070.1013500.29%
2024/06/28371.8700.0071.1033590.83%
2024/06/271174.221.273.0074.009.83802.58%
2024/06/250.270.1700.0070.000.24380.04%
2024/06/2100.00169.9069.60-1456-0.22%
2024/06/2000.00969.2471.20-9458-1.96%
2024/06/19269.25268.7069.0004630.00%
2024/06/11172.10174.3070.0005000.00%
2024/06/07271.85472.6572.70-2509-0.39%
2024/05/30175.8000.0076.5016230.16%
2024/05/27176.8000.0075.6017630.13%
2024/05/22177.201677.2377.10-15839-1.79%
2024/05/211378.086577.1177.00-52844-6.15%
2024/05/20480.68480.4582.0008490.00%
2024/05/1700.00274.8075.90-2863-0.23%
2024/05/162171.7300.0071.50218922.35%
2024/05/151771.7800.0071.90179381.81%
2024/05/141170.39272.6573.0099590.94%
2024/05/132270.39271.8071.50209592.08%
2024/05/09268.2500.0068.2029640.21%
2024/05/07170.80167.6067.7009730.00%
2024/05/03271.8000.0071.8029670.21%
2024/05/02171.7000.0072.7019630.10%
2024/04/30674.3700.0073.5069610.62%
2024/04/29167.303.170.0270.90-2.1945-0.22%
2024/04/253.165.8900.0065.303.19320.33%
2024/04/2300.00168.0068.40-1919-0.11%
2024/04/22169.30069.2068.1019190.10%
2024/04/19169.4100.0069.2019140.11%
2024/04/18270.0000.0069.0029090.22%
2024/04/160.571.591172.1571.70-10.5905-1.16%
2024/04/153.575.65278.5073.701.58950.17%
2024/04/12379.90179.8079.8028800.23%
2024/04/11281.35183.1080.7018720.11%
2024/04/10181.60181.0080.5008660.00%
2024/04/09180.3000.0080.2018630.12%
2024/04/08181.2000.0081.2018580.12%
2024/04/0300.00282.9082.90-2853-0.23%
2024/04/022.183.5700.0084.102.18470.25%
2024/04/01384.203.284.2686.90-0.2835-0.02%
2024/03/291.482.104180.9680.00-39.6813-4.87%
2024/03/281384.221787.4983.10-4787-0.51%
國邑*吸入新藥完成澳洲一期臨床 預計年底完成與美國FDA Pre-IND會議Anue鉅亨-28天前
國邑* 相關文章
國邑* 相關影音